{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:55:52Z","timestamp":1790740552439,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T00:00:00Z","timestamp":1529971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00726-018-2605-8","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T07:50:04Z","timestamp":1529999404000},"page":"1279-1288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro"],"prefix":"10.1007","volume":"50","author":[{"given":"Shigeru","family":"Murakami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayuko","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azusa","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Takenaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,26]]},"reference":[{"key":"2605_CR1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2174\/1574887109666141216102458","volume":"9","author":"L Abenavoli","year":"2014","unstructured":"Abenavoli L, Peta V (2014) Role of adipokines and cytokines in non-alcoholic fatty liver disease. Rev Recent Clin Trials 9:134\u2013140","journal-title":"Rev Recent Clin Trials"},{"key":"2605_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1042\/bj2560251","volume":"256","author":"OI Aruoma","year":"1998","unstructured":"Aruoma OI, Halliwell B, Hoey BM, Butler J (1998) The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochem J 256:251\u2013255","journal-title":"Biochem J"},{"key":"2605_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.lfs.2015.05.019","volume":"135","author":"ML Bonfleur","year":"2015","unstructured":"Bonfleur ML, Borck PC, Ribeiro RA, Caetano LC, Soares GM, Carneiro EM, Balbo SL (2015) Improvement in the expression of hepatic genes involved in fatty acid metabolism in obese rats supplemented with taurine. Life Sci 135:15\u201321","journal-title":"Life Sci"},{"key":"2605_CR4","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/hep.20466","volume":"40","author":"JD Browning","year":"2004","unstructured":"Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40:1387\u20131395","journal-title":"Hepatology"},{"key":"2605_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrgastro.2010.21","volume":"7","author":"E Brunt","year":"2010","unstructured":"Brunt E (2010) Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 7:195\u2013203","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2605_CR6","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1007\/s10620-006-9359-y","volume":"51","author":"SW Chen","year":"2006","unstructured":"Chen SW, Chen YX, Shi J, Lin Y, Xie WF (2006) The restorative effect of taurine on experimental nonalcoholic steatohepatitis. Dig Dis Sci 51:2225\u20132234","journal-title":"Dig Dis Sci"},{"key":"2605_CR7","doi-asserted-by":"publisher","first-page":"e12602","DOI":"10.1371\/journal.pone.0012602","volume":"5","author":"J Das","year":"2010","unstructured":"Das J, Ghosh J, Manna P, Sil PC (2010) Protective role of taurine against arsenic-induced mitochondria-dependent hepatic apoptosis via the inhibition of PKCdelta\u2013JNK pathway. PLoS One 5:e12602","journal-title":"PLoS One"},{"key":"2605_CR8","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.bpg.2014.07.008","volume":"28","author":"P Dietrich","year":"2014","unstructured":"Dietrich P, Hellerbrand C (2014) Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Pract Res Clin Gastroenterol 28:637\u2013653","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2605_CR9","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Investig 115:1343\u20131351","journal-title":"J Clin Investig"},{"key":"2605_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3177\/jnsv.57.144","volume":"57","author":"N Fukuda","year":"2011","unstructured":"Fukuda N, Yoshitama A, Sugita S, Fujita M, Murakami S (2011) Dietary taurine reduces hepatic secretion of cholesteryl ester and enhances fatty acid oxidation in rats fed a high-cholesterol diet. J Nutr Sci Vitaminol 57:144\u20131449","journal-title":"J Nutr Sci Vitaminol"},{"key":"2605_CR11","doi-asserted-by":"publisher","first-page":"R1710","DOI":"10.1152\/ajpregu.00677.2010","volume":"301","author":"CL Gentile","year":"2011","unstructured":"Gentile CL, Nivala AM, Gonzales JC, Pfaffenbach KT, Wang D, Wei Y, Jiang H, Orlicky DJ, Petersen DR, Pagliassotti MJ, Maclean KN (2011) Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease. Am J Physiol Regul Integr Comp Physiol 301:R1710\u20131722","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2605_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1152\/physrev.1992.72.1.101","volume":"72","author":"RJ Huxtable","year":"1992","unstructured":"Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72:101\u2013163","journal-title":"Physiol Rev"},{"key":"2605_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0278-6915(97)00146-4","volume":"36","author":"DF Hwang","year":"1998","unstructured":"Hwang DF, Wang LC, Cheng HM (1998) Effect of taurine on toxicity of copper in rats. Food Chem Toxicol 36:239\u2013244","journal-title":"Food Chem Toxicol"},{"key":"2605_CR14","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s10620-015-3977-1","volume":"61","author":"SH Ibrahim","year":"2016","unstructured":"Ibrahim SH, Hirsova P, Malhi H, Gores GJ (2016) Animal models of nonalcoholic steatohepatitis: eat, delete, and inflame. Dig Dis Sci 61:1325\u20131336","journal-title":"Dig Dis Sci"},{"key":"2605_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jphs.2015.08.007","volume":"129","author":"T Ito","year":"2015","unstructured":"Ito T, Yoshikawa N, Ito H, Schaffer SW (2015) Impact of taurine depletion on glucose control and insulin secretion in mice. J Pharmacol Sci 129:59\u201364","journal-title":"J Pharmacol Sci"},{"key":"2605_CR16","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.tem.2012.06.008","volume":"23","author":"AM James","year":"2012","unstructured":"James AM, Collins Y, Logan A, Murphy MP (2012) Mitochondrial oxidative stress and the metabolic syndrome. Trends Endocrinol Metab 23:429\u2013434","journal-title":"Trends Endocrinol Metab"},{"key":"2605_CR17","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1007\/s00726-011-0962-7","volume":"42","author":"CJ Jong","year":"2012","unstructured":"Jong CJ, Azuma J, Schaffer S (2012) Mechanism underlying the antioxidant activity of taurine: prevention of mitochondrial oxidant production. Amino Acids 42:2223\u20132232","journal-title":"Amino Acids"},{"key":"2605_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/BF01345280","volume":"15","author":"MD Kerai","year":"1998","unstructured":"Kerai MD, Waterfield CJ, Kenyon SH, Asker DS, Timbrell JA (1998) Taurine: protective properties against ethanol-induced hepatic steatosis and lipid peroxidation during chronic ethanol consumption in rats. Amino Acids 15:53\u201376","journal-title":"Amino Acids"},{"key":"2605_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1055\/s-0028-1091978","volume":"28","author":"M Lazo","year":"2008","unstructured":"Lazo M, Clark JM (2008) The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 28:339\u2013350","journal-title":"Semin Liver Dis"},{"key":"2605_CR20","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1002\/mnfr.201300150","volume":"57","author":"S Lin","year":"2013","unstructured":"Lin S, Hirai S, Yamaguchi Y, Goto T, Takahashi N, Tani F, Mutoh C, Sakurai T, Murakami S, Yu R, Kawada T (2013) Taurine improves obesity-induced inflammatory responses and modulates the unbalanced phenotype of adipose tissue macrophages. Mol Nutr Food Res 57:2155\u20132165","journal-title":"Mol Nutr Food Res"},{"key":"2605_CR21","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2174\/1389450116666150427155342","volume":"16","author":"W Liu","year":"2015","unstructured":"Liu W, Baker SS, Baker RD, Zhu L (2015) Antioxidant mechanisms in nonalcoholic fatty liver disease. Curr Drug Targets 16:1301\u20131314","journal-title":"Curr Drug Targets"},{"key":"2605_CR22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1159\/000139395","volume":"52","author":"S Murakami","year":"1996","unstructured":"Murakami S, Yamagishi I, Asami Y, Ohta Y, Toda Y, Nara Y, Yamori Y (1996) Hypolipidemic effect of taurine in stroke-prone spontaneously hypertensive rats. Pharmacology 52:303\u2013313","journal-title":"Pharmacology"},{"key":"2605_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0021-9150(97)00121-4","volume":"133","author":"S Murakami","year":"1997","unstructured":"Murakami S, Yamagishi I, Sato M, Tomisawa K, Nara Y, Yamori Y (1997) ACAT inhibitor HL-004 accelerates the regression of hypercholesterolemia in stroke-prone spontaneously hypertensive rats (SHRSP): stimulation of bile acid production by HL-004. Atherosclerosis 133:97\u2013104","journal-title":"Atherosclerosis"},{"key":"2605_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0024-3205(98)00536-0","volume":"64","author":"S Murakami","year":"1999","unstructured":"Murakami S, Kondo-Ohta Y, Tomisawa K (1999) Improvement in cholesterol metabolism in mice given chronic treatment of taurine and fed a high-fat diet. Life Sci 64:83\u201391","journal-title":"Life Sci"},{"key":"2605_CR25","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1016\/S0024-3205(02)01507-2","volume":"70","author":"S Murakami","year":"2002","unstructured":"Murakami S, Kondo Y, Toda Y, Kitajima H, Kameo K, Sakono M, Fukuda N (2002) Effect of taurine on cholesterol metabolism in hamsters: up-regulation of low density lipoprotein (LDL) receptor by taurine. Life Sci 70:2355\u20132366","journal-title":"Life Sci"},{"key":"2605_CR26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00726-009-0247-6","volume":"38","author":"S Murakami","year":"2010","unstructured":"Murakami S, Sakurai T, Tomoike H, Sakono M, Nasu T, Fukuda N (2010) Prevention of hypercholesterolemia and atherosclerosis in the hyperlipidemia- and atherosclerosis-prone Japanese (LAP) quail by taurine supplementation. Amino Acids 38:271\u2013278","journal-title":"Amino Acids"},{"key":"2605_CR27","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/1440-1681.12534","volume":"43","author":"S Murakami","year":"2016","unstructured":"Murakami S, Fujita M, Nakamura M, Sakono M, Nishizono S, Sato M, Imaizumi K, Mori M, Fukuda N (2016) Taurine ameliorates cholesterol metabolism by stimulating bile acid production in high-cholesterol-fed rats. Clin Exp Pharmacol Physiol 43:372\u2013378","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2605_CR28","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1742-7843.2008.00208.x","volume":"102","author":"S Parvez","year":"2008","unstructured":"Parvez S, Tabassum H, Banerjee BD, Raisuddin S (2008) Taurine prevents tamoxifen-induced mitochondrial oxidative damage in mice. Basic Clin Pharmacol Toxicol 102:382\u2013387","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2605_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00726-012-1414-8","volume":"46","author":"SW Schaffer","year":"2014","unstructured":"Schaffer SW, Jong CJ, Ito T, Azuma J (2014) Role of taurine in the pathologies of MELAS and MERRF. Amino Acids 46:47\u201356","journal-title":"Amino Acids"},{"key":"2605_CR30","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/978-3-319-15126-7_47","volume":"803","author":"K Shimada","year":"2015","unstructured":"Shimada K, Jong CJ, Takahashi K, Schaffer SW (2015) Role of ROS production and turnover in the antioxidant activity of taurine. Adv Exp Med Biol 803:581\u2013596","journal-title":"Adv Exp Med Biol"},{"key":"2605_CR31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1089\/ars.2016.6776","volume":"26","author":"S Spahis","year":"2017","unstructured":"Spahis S, Delvin E, Borys JM, Levy E (2017) Oxidative stress as a critical factor in nonalcoholic fatty liver disease pathogenesis. Antioxid Redox Signal 26:519\u2013541","journal-title":"Antioxid Redox Signal"},{"key":"2605_CR32","doi-asserted-by":"publisher","first-page":"18070","DOI":"10.3748\/wjg.v20.i48.18070","volume":"20","author":"S Stojsavljevi\u0107","year":"2014","unstructured":"Stojsavljevi\u0107 S, Gomer\u010di\u0107 Pal\u010di\u0107 M, Virovi\u0107 Juki\u0107 L, Smir\u010di\u0107 Duvnjak L, Duvnjak M (2014) Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 20:18070\u201318091","journal-title":"World J Gastroenterol"},{"key":"2605_CR33","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1093\/emboj\/cdf656","volume":"21","author":"T Suzuki","year":"2002","unstructured":"Suzuki T, Suzuki T, Wada T, Saigo K, Watanabe K (2002) Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases. EMBO J 21:6581\u20136589","journal-title":"EMBO J"},{"key":"2605_CR34","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1210\/en.2005-1007","volume":"147","author":"N Tsuboyama-Kasaoka","year":"2006","unstructured":"Tsuboyama-Kasaoka N, Shozawa C, Sano K, Kamei Y, Kasaoka S, Hosokawa Y, Ezaki O (2006) Taurine (2-aminoethanesulfonic acid) deficiency creates a vicious circle promoting obesity. Endocrinology 147:3276\u20133284","journal-title":"Endocrinology"},{"key":"2605_CR35","doi-asserted-by":"publisher","first-page":"G1274","DOI":"10.1152\/ajpgi.2001.280.6.G1274","volume":"280","author":"E Waters","year":"2001","unstructured":"Waters E, Wang JH, Redmond HP, Wu QD, Kay E, Bouchier-Hayes D (2001) Role of taurine in preventing acetaminophen-induced hepatic injury in the rat. Am J Physiol Gastrointest Liver Physiol 280:G1274\u20131279","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2605_CR36","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1093\/jn\/129.9.1705","volume":"129","author":"H Yokogoshi","year":"1999","unstructured":"Yokogoshi H, Mochizuki H, Nanami K, Hida Y, Miyachi F, Oda H (1999) Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. J Nutr 129:1705\u20131712","journal-title":"J Nutr"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00726-018-2605-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-018-2605-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-018-2605-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T19:30:52Z","timestamp":1561491052000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00726-018-2605-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,26]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["2605"],"URL":"https:\/\/doi.org\/10.1007\/s00726-018-2605-8","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,26]]},"assertion":[{"value":"25 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest in association with the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}